George Clark - May 10, 2022 Form 4 Insider Report for Biohaven Pharmaceutical Holding Co Ltd. (BHVN)

Role
VP, Chief Accounting Officer
Signature
/s/ George Clark
Stock symbol
BHVN
Transactions as of
May 10, 2022
Transactions value $
-$473,340
Form type
4
Date filed
5/12/2022, 08:58 PM
Previous filing
Jan 24, 2022
Next filing
Oct 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHVN Common Shares Options Exercise $121K +2.25K +37.41% $53.76* 8.27K May 10, 2022 Direct F1
transaction BHVN Common Shares Sale -$594K -4.2K -50.82% $141.50* 4.07K May 10, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHVN Employee Stock Option (right to buy) Options Exercise $0 -2.25K -50% $0.00 2.25K May 10, 2022 Common Shares 2.25K $53.76 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
F2 The shares underlying this option vest in four equal installments on December 5, 2019, 2020, 2021 and 2022, subject to the reporting person's continued service with the issuer at each vesting date.